Vertex Pharmaceuticals Incorporated Profile Avatar - Palmy Investing

Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have spe…

Biotechnology
US, Boston [HQ]
Strategy & Leadership

Officers & BofD Beta

  • Form 3/4/5
  • Proxy DEF-14A

Total Compensation

- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position Research Last Appearance
Altshuler David
EVP, Chief Scientific Officer
11/19/24 [Form 4]
Kewalramani Reshma
CEO & President
Also inside the BofD
11/12/24 [Form 4]
Biller Jonathan
EVP and Chief Legal Officer
10/03/24 [Form 4]
Leiden Jeffrey M
Executive Chairman
Also inside the BofD
09/04/24 [Form 4]
Bozic Carmen
EVP and CMO
08/08/24 [Form 4]
Atkinson Edward Morrow Iii
EVP, Chief Technical Ops. Off.
06/13/24 [Form 4]
Sachdev Amit
EVP Chief Patient & Ext Af Off
06/07/24 [Form 4]
Tatsis Ourania
EVP, Chief Reg. & Quality Off.
06/05/24 [Form 4]
Ambrose Kristen
SVP & Chief Accounting Officer
04/03/24 [Form 4]
End of VRTX's Analysis
CIK: 875320 CUSIP: 92532F100 ISIN: US92532F1003 LEI: - UEI: -
Secondary Listings